Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies-Reference-Cited by-同舟云学术

Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies

Published:2006-01-01 Issue:2 Volume:44 Page:
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:
Short-container-title:

Author:

Mollenhauer Brit,Bibl Mirko,Wiltfang Jens,Steinacker Petra,Ciesielczyk Barbara,Neubert Karin,Trenkwalder Claudia,Otto Markus

Abstract

AbstractThe intra vitam diagnosis of different dementias is still based on clinical grounds. So far, no technical investigations have been available to support these diagnoses. For tau protein and β-amyloid

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/CCLM.2006.035/pdf

Reference14 articles.

1. EM Clinical diagnosis of Alzheimer s disease : report of the NINCDS - ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer s Disease;McKhann;Neurology,1984

2. Differential diagnosis of Alzheimer s disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine;Buerger;Arch Neurol,2002

3. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy - bodies report of the consortium on DLB international workshop;McKeith;Neurology,1996

4. Decreased β and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease;Sunderland;amyloid J Am Med Assoc,2003

5. Follow - up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer s disease;Mollenhauer;J Neural Transm,2005

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians;Neurology and Therapy;2024-05-08

2. CSF α-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies;Alzheimer Disease & Associated Disorders;2022-09-12

3. Prognosis of Alzheimer’s Disease Using Quantitative Mass Spectrometry of Human Blood Plasma Proteins and Machine Learning;International Journal of Molecular Sciences;2022-07-18

4. Plasma MIA , CRP , and Albumin Predict Cognitive Decline in Parkinson's Disease;Annals of Neurology;2022-06-07

5. Cross-Sectional and Longitudinal Hippocampal Atrophy, Not Cortical Thinning, Occurs in Amyloid-Negative, p-Tau-Positive, Older Adults With Non-Amyloid Pathology and Mild Cognitive Impairment;Frontiers in Neuroimaging;2022-06-02